Ikena Oncology Inc (IKNA)
1.45
+0.06
(+4.32%)
USD |
NASDAQ |
Mar 28, 11:52
Ikena Oncology Cash from Investing (TTM): 64.14M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 64.14M |
September 30, 2023 | 54.27M |
June 30, 2023 | 58.16M |
March 31, 2023 | 55.96M |
December 31, 2022 | -99.28M |
September 30, 2022 | -110.33M |
June 30, 2022 | -146.30M |
Date | Value |
---|---|
March 31, 2022 | -166.97M |
December 31, 2021 | -1.76M |
September 30, 2021 | 1.828M |
June 30, 2021 | 2.012M |
March 31, 2021 | 2.20M |
December 31, 2020 | 2.922M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-166.97M
Minimum
Mar 2022
64.14M
Maximum
Dec 2023
-21.78M
Average
2.012M
Median
Jun 2021
Cash from Investing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -0.017M |
Palatin Technologies Inc | 9.293M |
iBio Inc | 8.285M |
Theriva Biologics Inc | -0.237M |
Ampio Pharmaceuticals Inc | -- |